| OSI-420 |
Desmethyl Erlotinib |
183320-51-6 |
| Erlotinib iMpurity B |
厄洛替尼杂质B |
183321-83-7 |
| Erlotinib impurity A |
厄洛替尼杂质A |
183321-85-9 |
| AM 251 |
1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-(哌啶-1-基)-1H-吡唑-3-甲酰胺 |
183232-66-8 |
| 2-broMo-3-Methoxybutane-1,4-diol |
2-溴-3-甲氧基丁烷-1,4-二醇 |
183194-69-6 |
| 1-aMino-2-Methylenecyclopropanecarboxylic acid (Hydrochloride) |
1-氨基-2-亚甲基环丙烷甲酸盐酸盐 |
181712-46-9 |
| N-(2,2,2-Trifluoroethyl)-9-(4-[4-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]piperidin-1-yl]butyl)-9H-fluorene-9-carboxamide |
N-(2,2,2-三氟乙基)-9-(4-[4-[4'-(三氟甲基)[1,1'-联苯]-2-甲酰氨基]哌啶-1-基]丁基)-9H-芴-9-甲酰胺 |
182431-12-5 |
| (R)-Methyl 1-(MethoxyaMino)-1-oxo-3-phenylpropan-2-ylcarbaMate |
(R) - (1-(甲氧基氨基)-1-氧代-3-苯基丙-2-基)氨基甲酸甲酯 |
166742-96-7 |
| (S)-Ornidazole |
左旋奥硝唑 |
166734-83-4 |
| (R)-benzyl Methyl(1,2,3,4-tetrahydroquinolin-3-yl)carbaMate |
(R) - 苄基甲基(1,2,3,4-四氢喹啉-3-基)氨基甲酸酯 |
166742-98-9 |
| 1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one, 11-chloro-2,3,3a,12b-tetrahydro-2-Methyl-, (3aR,12bS)-rel- |
阿塞那平中间体杂质 |
165890-26-6 |
| PD 151746 |
PD151746 |
179461-52-0 |
| SDZ 220-581 (AMMoniuM salt) |
(S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸单铵盐 |
179411-94-0 |
| SDZ 220-581 (hydrochloride) |
(S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸盐酸盐 |
179411-93-9 |
| Caspofungin acetate |
醋酸卡泊芬净 |
179463-17-3 |
| 6,7-diethoxyquinazolin-4(3H)-one |
6,7-二乙氧基喹唑啉-4-酮 |
179246-15-2 |
| ethyl 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxylate (dihydrochloride) |
5-[4-[4-(5-氰基-1H-吲哚-3-基)丁基]-1-哌嗪基]-2-苯并呋喃羧酸乙酯盐酸盐 |
163521-09-3 |
| 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-Benzofurancarboxylic acid |
维拉佐酮羧基酸 |
163521-19-5 |
| Vilazodone Intermediate |
5-(哌嗪-1-基)苯并呋喃-2-羧酸乙酯 |
163521-20-8 |
| VILAZODONE |
维拉佐酮 |
163521-12-8 |
